[Abin da ke biyowa wani yanki ne daga littafin Julie Ponesse, Lokacin Mu Na Ƙarshe.]
Ofaya daga cikin abubuwan da muka koya cikin shekaru ukun da suka gabata shine kawai nawa ka'idojin da aka sanya a cikin martanin Covid, yadda tattalin arziƙi ya juya fasahar rigakafin ta zama injin ribar masana'antu. Ɗaya daga cikin mahimman shaida game da wannan ya fito ne daga rahoton Pfizer, wanda FDA ta fitar a bara a matsayin wani ɓangare na umarnin kotun Amurka, wanda ke ɗauke da abin da Naomi Wolf ta kira "shaida mafi girma da laifin cin zarafin bil'adama a tarihin jinsinmu."
Rahoton ya nuna rashin jituwa mai yawa tsakanin yadda ake sayar da allurar ga jama'a da abin da Pfizer ya sani game da su kafin a fitar da su kasuwa. Yana nuna:
- Pfizer ya san allurar da suka dogara da kwayar halittarsu ba ta da inganci tun farkon Nuwamba 2020 (tare da sakamako na uku mafi yawan alurar riga kafi shine Covid, kanta)
- Jim kadan bayan da allurar rigakafin ta zo kasuwa, Pfizer ya dauki hayar ma’aikata 2,400 na cikakken lokaci don aiwatar da rahotannin da ba su dace ba (gaskiya mai ban mamaki da aka ba da al'adun shiru wanda ya hana yawancin abubuwan da ba su da kyau ko da a sanar da su, ko sarrafa su ta, likitoci)
- cewa allurar rigakafi na haifar da myocarditis a cikin mako guda bayan allura
- Nanoparticles na lipid na harbin ba sa zama a wurin allurar amma ana rarraba su cikin sauri a cikin jiki zuwa kwakwalwa, hanta, saifa, da ovaries inda za su kasance na dindindin.
- asymmetry tsakanin muggan abubuwan da aka bayyana wa jama'a (sanyi, gajiya, kumburi a wurin allura) da kuma waɗanda ke cikin takaddun (jini, gudan jini, cututtukan jijiyoyin jiki, palsy Bell, ciwon Guillain-Barré)
- an samu mutuwar mutane 61 daga shanyewar jiki, rabinsu ya faru ne cikin sa'o'i 48 da aka yi musu allura
Waɗannan su ne abubuwan da Pfizer ya sani. Waɗannan su ne abubuwan da Pfizer bai bayyana wa jama'a ba. Waɗannan su ne abubuwan da suka mayar da mu turkey da Pfizer, mai yanka.
An ce babu wani tarihi da ya yi daidai da allurar rigakafin Covid: samfurin gwaji da aka yi kasuwa sosai a kan sikelin duniya, wanda ya sami kusan cikakkiyar tallafi daga masu tsara manufofi. Matsakaicin kuɗin da ake ciki ya kusan wuce fahimta. Pfizer's 2023 "Bita na Shekara-shekara" ya ce: "2022 shekara ce da muka saita mafi girman lokaci a cikin nau'ikan kuɗi da yawa." A waccan shekarar, kudaden shiga na Pfizer ya kasance rikodin rikodin dala biliyan 100.3, 38% yana fitowa daga allurar Pfizer-BioNTech.
Duk da yake ba boyayye ba ne cewa kamfanonin harhada magunguna suna kashe kaso mai yawa na kasafin kuɗinsu wajen tallata tallace-tallace, yana da wuya a yi tunanin ana sayar da samfuran magunguna kamar motoci ko lipstick. Amma su ne. Wataƙila ma fiye da haka. A cikin 2022, Pfizer ya kashe dala biliyan 2.8 akan talla, kashi 2% na kudaden shiga da suka samu daga allurar Pfizer-BioNTech. Amma yadda ake siyar da kayayyakin magunguna aiki ne mai sarkakiya.
Abu daya da muka samu a cikin rahoton Pfizer shine dogon jerin gudummawar gudummawa ga ƙungiyoyin da suka ƙarfafa yin amfani da rigakafin, da/ko magance shakkun rigakafin kai tsaye. Pfizer ba zai iya samar da tallace-tallacen da ke ba da izini ba - wanda zai kasance a bayyane sosai - amma za su iya ba da gudummawar ƙungiyoyi daban-daban, kwalejojin kiwon lafiya, kafofin watsa labaru, har ma da mujallu na likitanci waɗanda ke haɓaka amfani da alluran rigakafi, magance shakkuwar rigakafin, da umarnin tallafi.
Daga cikin gudummawar agaji na Pfizer, rahoton ya lissafa: $200,000 zuwa Cibiyar Nazarin Yara ta Amurka, $ 100,000 ga Kwalejin Likitocin gaggawa ta Amurka don amincin Alurar riga kafi PSAs, da $337,550 zuwa Gangamin Fadakarwa na Pneumonia Association na Amurka. (Idan kuna son haɓaka ɗaukar rigakafin ƙwayar cuta na numfashi, yana da ma'ana mai ma'ana don tallata ciwon huhu a matsayin mummunan sakamako na Covid.)
Har ila yau, abin lura ne cewa Pfizer mai ba da gudummawa ne na yau da kullum ga jami'o'i, mafi yawansu sun ba da izinin samfurin su. Lokacin da jaridu suka fara ba da rahoton labarina a cikin kaka na 2021, da Toronto Star tuntuɓi Arthur Caplan, Daraktan Da'a na Likita a Cibiyar Kiwon Lafiya ta NYU, don yin sharhi. Amsar da ya bayar ita ce "Na shafe shekaru 9 ina aikin rigakafin kuma ba zan wuce ta a cikin aji na ba." Abin da na gano tun daga lokacin shine Pfizer ya ba da gudummawar $20,000 ga NYU don wani shiri don magance rashin fahimta game da rigakafin Covid-19. Sakamakon haka, albashin Caplan wata jami'a ce wacce ta karɓi kuɗi kai tsaye daga Pfizer don haɓaka ɗaukar rigakafinta na Covid.
Muna da irin wannan yanayin a Kanada. A cikin 2020, Pfizer Canada ya ba da gudummawar $600K ga McGill "Interdisciplinary Initiative infection and Immunity" (M14). M14 yana haɓaka ɗaukar rigakafin Covid da kuma kuɗin Pfizer M14. Kuma "19toZero," wata "ƙungiyar mai zaman kanta, mai zaman kanta" da nufin haɓaka amincin rigakafin, jihohi akan gidan yanar gizon su (duk da cewa a cikin kyakkyawan bugu): "…An ba da tallafin wannan tashar ta hanyar tallafin magunguna ta Moderna Canada."
Komawa ga batun hangen nesa. Abin da muka sani, kuma ba mu sani ba, a lokacin rikicin Covid game da tsananin cutar, da aminci da ingancin fasahar da aka haɓaka don magance ta, kamfanonin da suka tsaya tsayin daka sun yi tasiri sosai daga yadda kamfanonin da suka tsaya don samun babban riba na kuɗi daga yadda muka amsa. Komai daga yadda kamfanoni da yawa suka tilasta wa dokar rigakafin zuwa ko iyaye mata za su bar 'ya'yansu suyi wasa tare da abokan da ba a yi musu allurar ba ya shafi layin kamfanoni kamar Pfizer da Moderna, kuma da alama sun yi daidai da dabara.
Amma gaskiyar cewa masana'antar harhada magunguna suna tsara manufofin kula da lafiya ta hanyar ƙungiyoyin bayar da shawarwari na waje ba sabon abu ba ne. Bari in ba da misalai guda biyu na wannan al'amari da ya wanzu a bayyane kafin 2020.
Misali 1: Cutar Opioid: A ra'ayin mazan jiya, opioids sun yi sanadiyar mutuwar Amurkawa rabin miliyan a cikin shekaru 20 da suka gabata. Purdue Pharma, wanda ya yi Oxycontin, ya haɓaka amfani da shi tsawon shekaru da yawa duk da tabbataccen shaidar yuwuwar sa na jaraba da wuce gona da iri. Takardun kotun sun nuna cewa Purdue ya kashe fiye da dala miliyan 200 akan talla kuma ya dauki nauyin 20,000 jin zafi "shirye-shiryen ilimi" a cikin ƙoƙari na motsa likitoci don tsara ƙarin opioids. Shekaru biyar bayan fitowar ta, OxyContin ya samar da kudaden shiga na shekara fiye da dala biliyan 1.
Misali 2: Tamiflu: A lokacin barkewar cutar mura ta 2005, Evan Morris, tsohon mai fafutuka na Genentech (kamfanin da ke siyar da Tamiflu don Roche), an ba da rahoton cewa ya biya ƙungiyoyin ɓangare na uku don haifar da fargaba game da kwayar cutar da buƙatar gwamnati ta tara Tamiflu. Da yawa daga cikin Sanatocin Amurka sun rubutawa shugaba George W. Bush game da damuwarsu, kuma shugaban ya ba da izinin tara tarin gaggawa wanda ya sayi dala biliyan 1 na maganin rigakafin cutar.
Waɗannan abubuwan da suka faru na haɗin gwiwa tsakanin ƙwararrun likitocin da masana'antar harhada magunguna na iya zama kamar abin mamaki amma da ƙyar bayanan ke ɓoye a cikin inuwa. A cikin 2002, babban editan New England Journal of Medicine Arnold Seymour Relman ya rubuta:
“Masana’antar harhada magunguna ne ke siyan wannan sana’a, ba wai kawai ta fannin aikin likita ba, har ma ta fuskar koyarwa da bincike, cibiyoyin ilimi na kasar nan suna ba wa kansu damar zama wakilan da ake biyansu albashi a masana’antar harhada magunguna.”
Kuma shekaru hudu kafin wannan, Dr. Matthias Rath ya rubuta a cikin Journal of Amirka Medical Association:
"A cikin karni na 20, masu zuba jari sun gina masana'antar harhada magunguna, makasudin shine maye gurbin (da haramtawa) magunguna masu inganci amma marasa haƙƙin mallaka tare da magungunan magunguna marasa inganci amma masu fa'ida da fa'ida sosai. Yanayin masana'antar harhada magunguna shine samun kuɗi daga cututtuka masu gudana."
A cikin ƙarin ƙididdiga, da British Medical Journal a cikin 2017 ya nuna cewa kashi 50% na editocin mujallun likitocin da suka fi tasiri a duniya suna karɓar kuɗi daga masana'antar harhada magunguna.
Abin da ya kamata duk wannan ya koya mana shiga 2020 shi ne, kawai saboda wani abu yana kasuwa, ba yana nufin yana da lafiya ba. Domin kawai ana siyar da samfur ko kuma yana da riba sosai, ba yana nufin yana da aminci ba. Kuma kawai saboda an amince da samfur daga jami'a ko kwalejin likita, ko ma ta kwamitin Nobel, ba yana nufin yana da lafiya ba. Akasin haka, shaidun sun nuna cewa haɗin gwiwa tsakanin kamfanonin magunguna da manyan cibiyoyi ya kasance gama gari tun kafin 2020. Gaskiyar cewa duka tsananin cutar Covid a matsayin kwayar cuta, da aminci da ingancin harbin Covid sun yi ƙima sosai bai kamata ya ba mu mamaki ba. Su ne farar swans na likitancin karni na 21. Kuma da bai kamata su wargaza mana rashin laifi ba domin bayanai ne da ya kamata mu yi riko da su tun farko.
-
Dokta Julie Ponesse, 2023 Brownstone Fellow, farfesa ce a fannin ɗabi'a wadda ta koyar a Kwalejin Jami'ar Huron ta Ontario na tsawon shekaru 20. An ba ta hutu kuma an hana ta shiga harabarta saboda umarnin rigakafin. Ta gabatar da shi a jerin Faith and Democracy a ranar 22, 2021. Dr. Ponesse yanzu ya ɗauki sabon matsayi tare da Asusun Demokraɗiyya, wata ƙungiyar agaji ta Kanada mai rijista da nufin haɓaka 'yancin ɗan adam, inda take aiki a matsayin ƙwararren masaniyar ɗabi'a.
Duba dukkan posts
